Global Pharmaceuticals & Biotech Healthy potentially undervalued

High Tide

Market Cap: CA$275.9m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Tasly Pharmaceutical Group

Market Cap: CN¥21.0b

Engages in the research, development, production, and sale of pharmaceuticals in China.

Arcutis Biotherapeutics

Market Cap: US$3.6b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

Regeneron Pharmaceuticals

Market Cap: US$67.4b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.

Sanofi

Market Cap: €91.8b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

CorMedix

Market Cap: US$692.7m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Hypera

Market Cap: R$14.3b

Operates as a pharmaceutical company in Brazil.

Zhejiang Jiuzhou Pharmaceutical

Market Cap: CN¥13.0b

Operates as contract development and manufacturing organization (CDMO) company in China and internationally.

Innovent Biologics

Market Cap: HK$155.9b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.

3SBio

Market Cap: HK$45.2b

An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.

Vetoquinol

Market Cap: €828.7m

A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.

Elanco Animal Health

Market Cap: US$12.3b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Supernus Pharmaceuticals

Market Cap: US$2.9b

A biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States.

Hugel

Market Cap: ₩2.5t

Develops and manufactures biopharmaceuticals in South Korea and internationally.

Shanghai Fosun Pharmaceutical (Group)

Market Cap: CN¥55.7b

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Dong-A Socio Holdings

Market Cap: ₩549.5b

Engages in the pharmaceutical business in South Korea.

Yunnan Baiyao GroupLtd

Market Cap: CN¥87.1b

Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.

Virbac

Market Cap: €2.7b

Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific.

Ardelyx

Market Cap: US$1.3b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

Dong-E-E-Jiao

Market Cap: CN¥29.9b

Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.

Bavarian Nordic

Market Cap: DKK 14.2b

Develops, manufactures, and supplies life-saving vaccines.

Tarsus Pharmaceuticals

Market Cap: US$2.9b

A commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.

Fennec Pharmaceuticals

Market Cap: US$356.1m

Operates as a commercial stage biopharmaceutical company in the United States.

Decibel Cannabis

Market Cap: CA$63.5m

An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.

Journey Medical

Market Cap: US$183.9m

A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Amoy Diagnostics

Market Cap: CN¥6.7b

Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.

Duopharma Biotech Berhad

Market Cap: RM 1.2b

Researches, develops, manufactures, markets, sells, imports, and distributes pharmaceutical products and medicines in Malaysia and internationally.

Dong-A ST

Market Cap: ₩350.4b

Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.

Perrigo

Market Cap: US$1.5b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Exagen

Market Cap: US$105.3m

Designs, develops, and commercializes various testing products under the AVISE brand in the United States.

WuXi AppTec

Market Cap: CN¥372.3b

An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.

Daewoong Pharmaceutical

Market Cap: ₩1.5t

Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.

China Resources Pharmaceutical Group

Market Cap: HK$28.3b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

United Laboratories International Holdings

Market Cap: HK$18.0b

An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.

Protara Therapeutics

Market Cap: US$231.0m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

Madrigal Pharmaceuticals

Market Cap: US$13.0b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.